Based on our hypothesis, maximum tumor growth reduction by targeted SA-5-Dox-LP formulation could be due to a combined effect of EGFR heterodimerization inhibitory action by SA-5 and maximized the activity of functionalized Dox liposome formulation due to its EPR effect. Here, EGFR is linked to neoplasm.